From patient-derived tumor organoids to personalized cancer therapy: advancing treatment for advanced solid tumors - Quiz - MDSpire

Utilizing Patient-Derived Tumor Organoids for Tailored Cancer Treatment: Progress in Managing Advanced Solid Tumors

  • By

  • Gang Wang

  • Zhibin Tan

  • Wenting Jia

  • Yuanyuan Liu

  • Huan Wang

  • Wenbo Sun

  • Weiwei Sun

  • Lu Meng

  • Yudong Zhang

  • Ning Liu

  • Feng Li

  • Hongchao Dong

  • July 20, 2026

Share

Original Source(s)

From patient-derived tumor organoids to personalized cancer therapy: advancing treatment for advanced solid tumors

  • by Gang Wang, Zhibin Tan, Wenting Jia, Yuanyuan Liu, Huan Wang, Wenbo Sun, Weiwei Sun, Lu Meng, Yudong Zhang, Ning Liu, Feng Li, Hongchao Dong

  • July 20, 2026

Related Content

Lipid metabolic plasticity in glioblastoma: mechanisms, tumor microenvironment remodeling, and therapeutic opportunities

Expression and prognostic significance of INSM1 compared with traditional neuroendocrine markers in mixed urothelial and small-cell carcinoma of the renal pelvis

Vitiligo-like depigmentation following neoadjuvant chemotherapy combined with pembrolizumab in early triple-negative breast cancer: a case report